Radiotherapy plus EGFR TKIs in non‐small cell lung cancer patients with brain metastases: an update meta‐analysis-Reference-Cited by-同舟云学术

Radiotherapy plus EGFR TKIs in non‐small cell lung cancer patients with brain metastases: an update meta‐analysis

Published:2016-03-14 Issue:6 Volume:5 Page:1055-1065
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Jiang Tao¹,Min Weijie²,Li Yanan²,Yue Zhijian²,Wu Chunyan³,Zhou Caicun¹

Affiliation:

1. Department of Medical Oncology Shanghai Pulmonary Hospital Tongji University School of Medicine 507 Zhengmin Road Yangpu District Shanghai 200433 China

2. Department of Neurosurgery Changhai Hospital Second Military Medical University 168 Changhai Road Yangpu District Shanghai 200433 China

3. Department of Pathology Shanghai Pulmonary Hospital Tongji University School of Medicine 507 Zhengmin Road Yangpu District Shanghai 200433 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.673

Reference54 articles.

1. Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of central nerve system metastases from non-small cell lung cancer

2. Systemic treatments for brain metastases from breast cancer, non-small cell lung cancer, melanoma and renal cell carcinoma: An overview of the literature

3. Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy

4. The biology of brain metastases—translation to new therapies

5. CNS metastases in non-small-cell lung cancer: Current role of EGFR-TKI therapy and future perspectives

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Intracranial Control After Intracranial Local Therapy on the Prognosis of Patients with Brain Metastasis of Lung Adenocarcinoma;Cancer Management and Research;2024-07

2. Effect of Different Timing of Local Brain Radiotherapy on Survival of EGFR-Mutated NSCLC Patients with Limited Brain Metastases;Brain Sciences;2023-09-03

3. Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort study and meta-analyses;Journal of Neuro-Oncology;2023-09

4. Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized, Open-Label, Phase 2 Clinical Trial;International Journal of Radiation Oncology*Biology*Physics;2023-03

5. Types of interventions;Translational Radiation Oncology;2023